BioCardia

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioCardia and other ETFs, options, and stocks.

About BCDA

BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and Avance Steerable Introducers.

CEO

Peter Alan Altman

CEOPeter Alan Altman

Employees

Employees20

Headquarters

Sunnyvale, California

HeadquartersSunnyvale, California

Founded

1994

Founded1994

Employees

Employees20

BCDA Key Statistics

Market cap

11.24M

Market cap11.24M

Price-Earnings ratio

-0.85

Price-Earnings ratio-0.85

Dividend yield

—

Dividend yield—

Average volume

74.44K

Average volume74.44K

High today

$2.49

High today$2.49

Low today

$2.08

Low today$2.08

Open price

$2.46

Open price$2.46

Volume

177.99K

Volume177.99K

52 Week high

$6.15

52 Week high$6.15

52 Week low

$1.63

52 Week low$1.63

People also own

Based on the portfolios of people who own BCDA. This list is generated using Robinhood data, and it’s not a recommendation.